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In a  recent paper  1 we reported a  series of experiments with Rosenow's anti- 
poliomyelitic serum, which is prepared in the horse by injections of streptococci 
derived from cases of poliomyelitis.  The present paper deals with a  similar test 
of a serum prepared in the horse by Nuzum  2 also by inoculating streptococci.  The 
two sera--Rosenow's and Nuzum's--while apparently similar, are  prepared  in 
somewhat different manner.  Thus Nuzum  3 has had the  exceptional and on the 
whole  extraordinary  experience  of  cultivating  streptococci  from  the  cerebro- 
spinal fluid removed by lumbar puncture from 90 per cent of  the  cases of epi- 
demic poliomyelitis studied, and he employs these spinal strains in the immuni- 
zation process.  Nuzum's reported results  stand  alon~; no  other bacteriologist 
employing a  strict technique has found bacteria either on microscopic examina- 
tion or in cultures in the cerebrospinal  fluid.  Perhaps the largest single experience 
reported is that of Abramson,  4 who published results of the bacteriological study 
of more than 1,200 fluids, all being negative for bacteria aside from a few instances 
of obvious contaminations. 
However, it is imperative to approach the question of immunological relation 
of certain streptococci to poliomyelitis without prejudice; and as Rosenow  5 and 
Nuzum  6 have reported the successful application of their sera, not only in  ex- 
periments on monkeys, but also in treating human cases of the disease, it is essen- 
tial that confirmatory  and, as far as possible, decisive tests be carried out by others. 
We  believe that  we  1 have  performed  a  decisive test  with  Rosenow's serum 
with the result of showing that under the conditions of the experiment it is de- 
void  of protective power  when  injected intraspinally against  experimental in- 
fection of monkeys with an active virus of poliomyelitis introduced intravenously. 
That  the conditions of the experiments were not too severe is indicated by the 
1 Amoss, H. L., and Eberson, F., J. Exp. Med., 1918,  xxvii, 309. 
2 Nuzum, J. W., J. Am. Med. Assn.,  1916,  lxvii, 1437. 
•  ~ Nuzum, J. W., J. Am. Med. Assn., 1917,  lxviii, 24. 
4 Abramson, H. L., J. Am. Med. Assn.,  1917,  lxviii, 546. 
5 Rosenow, E. C., J. Am. Med. Assn.,  1917, lxix, 1074. 
Nuzum, J. W., and Willy, R. G., J. Am. Med. Assn., 1917, lxix, 1247. 
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fact that perfect protection was secured from the serum of monkeys which had 
recovered from an experimenta~ poliomyelitic infection. 
Nuzum 7 has developed a somewhat more elaborate therapeutic technique than 
Rosenow.  Thus he bases his contention that his serum is therapeutically active 
<)n three sets of tests: (a) the neutralization of the virus in vitro;  (b) the neutrali- 
:zation of the virus in vivo by intraspinal injections of the serum; (c) the neutrali- 
zation of the virus in vivo by combined  intraspinal, intravenous, and intramus- 
cular injections of the serum.  Hence, in  order to  repeat and  check  Nuzum's 
experiments, the three modes of administering  the serum should be followed. 
Through the kindness of Dr.  Nuzum we were supplied  with 50 cc. 
.of his  serum.  This proved sufficient for one set of experiments, one 
monkey being used for each kind of test.  The series of tests is there- 
fore a  small  one; and had  the results not been absolutely consistent 
would have had no great value.  But as the results were consistent, and 
as the control tests with the serum of recovered monkeys were equally 
definite, no real doubt need be entertained regarding their significance. 
EXPERIMENTAL. 
The essential condition in dealing experimentally with the virus of 
poliomyelitis is  to  possess  a  specimen  of regular  and  high  potency; 
otherwise an element of irregularity is introduced which involves many 
separate inoculations.  Moreover, the virus should be so active as to 
produce infection uniformly when small doses of the Berkefeld filtrate 
are injected intracerebrally.  A virus which acts only when relatively 
large  doses  of  the  unfiltered  suspension  are  injected  is  certain  to 
produce  infection  irregularly  and,  in  addition,,  may  give  confusing 
results,  owing  to  traumatic  and  other  forms  of injury  to  the  brain 
substance  through  which paralysis,  weakness,  and  other  disturbing 
effects are produced. 
Neutralization  in  Vitro. 
When one minimum lethal dose of virus filtrate is incubated in the 
presence  or  absence  of  complement  8' 9 with  2  cc.  of  serum  from  a 
Nuzum, J. W., and Willy, R. G.,  J. Ir~/ect. Dis.,  1918, xxii, 258. 
8  Levaditi  and  Landsteiner, Compt.  rend. Soc. biol,  1910, lxviii, 311.  RSmer, 
P. H., and Joseph, K., Mi~nch. med, Woch., 1910, lvii, 568.  Flexner, S., and Lewis, 
P.  A., J,  Am, Med,  Assn.,  1910, liv,  1780,  Anderson,  J. F., and Frost, W. H., 
J.  Am. Med. Assn,,  1911, lvi, 663. 
9  Flexner, S., and Amoss, H. L.,  J. Exp.  Med.,  1918, xxviii,  11. HAROLD L.  AMOSS AND  FREDERICK  EBERSON  325 
monkey which has had experimental poliomyelitis and recovered,  the 
virus is rendered non-infective for a monkey on intracerebral inocula- 
tion.  Normal serum 9 does not  possess this power. 
Three experiments were carried  out  in precisely the  same manner, 
comparing Nuzum  and  Willy's  serum  with  normal  horse  serum  and 
immune monkey serum.  To 2 cc. of the serum to be tested there was 
added  0.2  cc.  of  a  Berkefeld  filtrate  of  a  5  per  cent  suspension  of 
glycerolated  active  poliomyelitic  monkey  cord.  The  mixture  was 
incubated  for 2  hours at 37 °  C. and placed at 4°C.  for  16  hours,  and 
then  injected  intracerebrally  into  a  normal monkey. 
Monkey A (Macacus rhesus), Control.--Apr. 12, 1918.  Injected intracerebrally 
the incubated mixture resulting from the addition of 0.2 cc. of virus filtrate to 2 
cc. of normal horse serum.  Apr.  16.  Excited and slow.  Apr.  17,  ~.m.,  pros- 
trate, moribund; p.m., died. 
Autopsy showed  characteristic changes of poliomyelitis in the brain and cord. 
Monkey B  (Macacus rhesus).--Apr.  12,  1918.  Injected  intracerebrally  the 
incubated mixture resulting from the addition Of 0.2 cc. of v'rus filtrate to 2 cc. 
of Nuzum and Willy's serum.  Apr.  19,  a.m., marked ataxia, both arms para- 
lyzed (Fig. 1) ; p.m.,.prostrate, etherized. 
Microscopic examination of the nervous tissues showed typical diffuse and ex- 
tensive poliomyelitic lesions  in medulla and spinal cord; marked perivascular in- 
filtration  (Fig.  2),  necrosis,  neurophagocytosis of  the  ganglion  cells, and  focal 
hemorrhages in the anterior horn of the cord. 
Monkey C (Macacus rhesus), Immune Control.--Apr. 12,  1918.  Injected in- 
tracerebrally the  incubated  mixture resulting  from the  addition  of 0.2  cc.  of 
virus filtrate to 2 cc. of serum drawn from a monkey which had been paralyzed 
from experimental poliomyelitis and recovered.  The monkey remained well. 
The  results  show  that  Nuzum  and  Willy's serum,  under  the  con- 
ditions  of  the  experiment,  possesses  no  more  neutralizing  power  for 
poliomyelitic virus  in vitro  than  does normal horse  serum. 
Neutralization in  Vivo. 
Nuzum  and  Willy's serum  was  subjected  in  the  following  experi- 
ments to the same test applied to Rosenow's antipoliomyelitic serum. 
This consists in the injection of a large dose of the virus intravenously 
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be  tested.  Flexner  and  Amoss  1°, 11  have  shown  that  under  these 
conditions  a  serum  possessing  no  neutralizing  properties  sets  up 
inflammatory  changes,  thus  opening  the  way  for  the  virus  to  pass 
from the blood stream into close relation with the meninges and cause 
infection.  Immune  serum,  on  the  other  hand,  while  causing  the 
same inflammatory changes, neutralizes  the virus as it passes  through 
and prevents infection. 
Monkey D (Macacus rhesus), Control.--Apr. 9,  1918,  5 p.m.  Injected intra- 
spinally 2 cc. of normal human serum.  Apr. 10, 11 a.m.  Injected intravenously 
50 cc. of a  centrifuged 5 per cent suspension of fresh poliomyelitic cord in iso- 
tonic salt  solution.  11.10  a.m.  Injected intraspinally  2 cc.  of normal human 
serum.  Apr.  11,  12  m.  Intraspinal  injection  of  2  cc.  of pooled  serum  from 
monkeys recovered  from  experimental  poliomyelitis.  The  dose  of serum  was 
repeated on the 2 following days.  The monkey remained well. 
Monkey E  (Macacusrhesus).--Apr. 9,  1918, 4.30 p.m.  Injected intraspinally 
2 cc.  of Nuzum and Willy's antipoliomyelitic serum.  Apr.  10,  11.15  a.m.  In- 
jected intravenously 50 cc. of a centrifuged 5 per cent suspension of fresh polio- 
myelitic cord in isotonic salt solution.  11.25  a.m.  Injected intraspinally  2 cc. 
of Nuzum and Willy's serum.  The intraspinal  injection of 2 cc. of the serum 
was repeated daily on the 3 succeeding days.  Apr.  16.  Slow; excitable.  Apr. 
17.  The  same.  Apr.  18.  Slow;  tires  easily.  Apr.  19.  Prostrate  (Fig.  3). 
3.10 p.m.  Died. 
Autopsy and microscopic examination of the tissues showed lesions of polio- 
myelitis, chiefly in the medulla and cervical enlargement of the cord.  They con- 
sisted  of the usual perivascular  infiltrations,  which were of moderate  severity, 
and of focal infiltrations of cells with polymorphous and fragmented nuclei.  The 
focal infiltrations  were sometimes near and sometimes away from blood vessels 
and were frequently in association with hemorrhages of considerable size.  More- 
over, nerve cell degeneration and neurophagocytosis had been progressing actively 
in the medulla  (Fig. 4)  and in the cervical portion of the cord.  These lesions 
indicate a severe poliomyelitis.  The number of focal hemorrhages (Fig. 4)  and 
their size are unusual in experimental poliomyelitis, although they are commonly 
found in human poliomyelitic nervous tissues. 
The experiments  show that while  the immune monkey serum  com- 
pletely neutralizes the virus as it passes through into the meninges and 
thus prevents  infection,  the  serum  of Nuzum  and  Willy possesses  no 
such power,  but acts in the same manner as normal horse serum. 
l0 Flexner, S., and Amoss, H. L., J. Exp. Med., 1914, xx, 249. 
H Flexner, S., and Amoss, H. L., J. Exp. Med., 1917, xxv, 525. HAROLD  L.  AMOSS  AND  FREDERICK  EBERSON  327 
Curative Experiments. 
Nuzum and Willy make the claim that their serum possesses cura- 
tive  properties  against  the  virus  in  experimental  poliomyelitis  in 
monkeys.  In  order  to  test  this  property  an experiment was made 
comparable with  their recorded test with Monkey 25  of their series. 
Their dose of virus given intracerebrally was  1 cc. of a 5 per cent sus- 
pension  of poliomyelitic cord.  In  the  experiment  about  to  be  re- 
corded only 0.5 cc. of a Berkefeld filtrate of a 5 per cent suspension of 
poliomyelitic monkey cord was used.  Thus the test in our hands was 
apparently less severe; however, the result is decisive. 
Monkey F (Macacus rhesus).--Apr. 11,  1918, 2.55 p.m.  Injected  intracere- 
brally under ether anesthesia 0.5 cc. of a Berkefeld filtrate of a 5 per cent sus- 
pension  of glycerolated poliomyelitic monkey  cord.  3  p.m.  Injected  intra- 
venously 15 cc. and intraspinally 2.5 cc. of Nuzum and Willy's serum.  Apr. 13. 
Injected  intramuscularly,  left  gluteal  region,  10  cc.  of  the  serum.  Apr.  14. 
Injected 10 cc. of the serum intramuscularly.  Apr. 16.  Ataxic; arms and legs 
weak; coarse  tremor present.  Apr.  17, 8 a.m.  Found dead. 
Autopsy and microscopic examination of the brain and cord showed typical 
diffuse lesions of poliomyelitis in the spinal cord and medulla.  (Fig. 5.)  There 
were extensive necrosis of the gray matter in the cord and marked typical peri- 
vascular infiltration in the intervertebral ganglia,  with hyaline degeneration and 
neurophagocytosis of the  ganglion  cells.  The medulla  showed  neurophagocy- 
tosis of nerve cells, focal infiltration of cells, of which many were polymorpho- 
nuclear,  due probably to the injection of horse serum. 
DISCUSSION. 
The  significance  of  the  experiments  is  self-evident.  Thus,  while 
the serum of the recovered monkeys completely neutralizes the virus 
of poliomyelitis in vitro or as it passes from the blood into the meninges 
after an aseptic inflammation has been induced in the latter, the serum 
prepared in the horse by Nuzum and Willy by means of injections of 
streptococci exhibited no neutralizing power whatever as far as could 
be detected.  Indeed, the indications are that the latter serum acts in 
the manner of normal horse serum and as such rather promotes than 
prevents  experimental poliomyelitic infection. 
This,  the  main  question  raised  by  the  experiments,  having  been 
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first  one  of  the  latter  relates  to  the  character  of  the  experimental 
evidence on which Rosenow  12 and Nuzum  6 base their claim that the 
antistreptococcic serum is neutralizing for the virus of poliomyelitis. 
It is significant that Rosenow  12 uses the expression "appears to have 
developed  neutralizing,  protective  and  curative  power against the 
virus  of  poliomyelitis."  The  tests  in  monkeys  can  be  made  so 
definite that there need be no room left for doubt as to what the results 
imply.  There are few pathogenic organisms which may be made to 
yield laboratory results as clear-cut as the virus of poliomyelitis. 
The basis of Nuzum's conclusion is also not definite.  He claims for 
his serum not merely neutralizing, protective power, but curative prop- 
erties and  the  ability to immunize monkeys passively  against  sub- 
sequent  intracerebral  inoculation  of  active  virus  suspension.  Al- 
together the number of criteria which enter into his calculations makes 
it  difficult to  arrive  at  a  decision.  The source of this uncertainty 
may reside in the quality of the virus which Nuzum employed.  As 
he injected 1 cc. of an unfiltered emulsion and even then failed in some 
instances to secure infection, the potency must have been low.  As we 
have  already pointed out,  a  virus with low virulence gives such ir- 
regular results as to make accurate deductions difficult or impossible 
to draw.  In our opinion, therefore, Nuzum's experimental evidence 
is inconclusive. 
Both Rosenow  ~, 13 and Nuzum  6 have treated human cases of polio- 
myelitis with their antistreptococcic sera.  The mode of application 
differs.  Thus Rosenow injects the serum intravenously, and Nuzum 
uses the combined intraspinal and intravenous injection and sometimes 
intramuscular injections.  The question as to the  value  of  the  evi- 
dence which is provided by the treatment of human cases of poliomy- 
elitis in the preparalytic stages,  so  called, in which, apparently, the 
therapeutic  results  are  supposed  to  be  striking,  cannot  now  be 
answered.  Our knowledge of the evolution of the preparalytic cases 
is still in its infancy.  The wide employment of lumbar puncture, in 
the last 2 years, for diagnostic purposes, is giving us for the first time 
data on which eventual conclusions may come to be based.  It would 
12 Rosenow, E. C., J. Am. Med. Assn., 1917, lxix, 261, 1074. 
13 Rosenow, E. C., J. Infect. Dis.. 1918, xxii, 379. HAROLD  L.  AMOSS AND  FREDERICK  EBERSON  329 
be  premature  to  undertake  to  interpret  those  data  now.  On  the 
other hand, little evidence has been adduced that the antistreptococcic 
serum injections have  affected the mortality in  the frankly paralytic 
cases, halted the advancing paralysis,  or brought about a more rapid 
and  complete  retrocession  of  the  existing  paralyses.  At  the  best, 
therefore, the case for the serum, as far as human therapy goes, should 
be considered unproved. 
There is, however, another subsidiary aspect of the subject.  Strep- 
tococcus infection  as  a  concomitant  or  terminal  or agonal  infection 
in epidemic poliomyelitis would now seem not to be uncommon.  It 
is not yet clear just when the invasion of streptococci into the nervous 
system takes place.  The fact that the cerebrospinal fluid, withdrawn 
under  sterile  conditions,  practically  never  contains  the  streptococci, 
would  seem  to  indicate  that  the  antemortem  invasion  is  sma 1 or 
agonal.  The point is very difficult to decide in human cases.  On the 
other  hand,  it  is  one  that  should  be easily  decided  experimentally. 
This  Smillie 14 has  attempted  to do.  Streptococci may be cultivated 
from the brain ~5 and cord and other viscera  14 of monkeys which have 
succumbed to experimental poliomyelitis.  When the spinal cord and 
medulla carrying streptococci are placed in 50 per cent sterile glycerol, 
the  streptococci  survive  for  weeks.  On  reinoculating  this  material 
intracerebrally  into  monkeys,  the  streptococci,  if  still  alive,  either 
merely  survive  or  multiply  somewhat  alongside  the  poliomyelitic 
virus.  Hence they can be recovered from the inoculated brain tissue. 
But if inoculation  is made with  a  filtered  virus  free  of streptococci, 
then, as Smillie has found, the presence or absence of those organisms 
is determined in great part by the stage of the disease and  the  state 
of the animal  at  the  time  the postmortem  examination  is performed 
and  cultures  are  taken.  An  animal  etherized  when  paralyzed  and 
still  strong  tends  not  to  show  the  presence  of  streptococci,  while  a 
moribund or already dead animal often does show their presence.  In 
14 Smillie,  W. G., J. Exp. Med., 1918, xxvii, 319. 
1:, Mathers,  G., J. Am. Med. Assn.,  1916, lxvii,  1019; J. Infect. Dis.,  1917, xx, 
113.  , Rosenow, E.  C., Towne, E. B., and Wheeler,  G. W., J. Am. Med. Assn., 
1916,  lxvii,  1202;  Science,  1916, xliv,  614; J. Am. Med. Assn.,  1917, lxviii,  280. 
Nuzum, J. W., and Herzog, M., J. Am..Med. Assn.,  1916, lxvii,  1205.  Nuzum, 
J. W., ibid.,  1916, Ixvii,  1437;  1917, lxvii', 24. 330  NUZUM'S  ANTIPOLIO~IYELITIC  SERUk~ 
other words, Smillie's view,which has still to be confirmed, would place 
the streptococcal invasion in poliomyelitis among the agonal and not 
the concomitant infections. 
It is on the basis of a  possible concomitant streptococcus infection 
of real importance for the termination of the disease that the employ- 
ment  of  an  antistreptococcic  serum  in  poliomyelitis  may  still  be 
urged, once it is proved  that  it has no specific action on the virus of 
poliomyelitis.  Even for this purpose we should need far more knowl- 
edge than we now possess to justify its employment. 
The  value,  in  general,  of  antistreptococcic  sera  in  combating 
streptococcus  infections  :s  unproved.  Streptococci  have  not  been 
cultivated  from  cases  of  poliomyelitis  in  man during  life.  Many, 
chiefly negative,  results  have been  obtained  with  cultures  from  the 
cerebrospinal fluid; and  it is in our opinion desirable to make many 
cultures from the blood before resorting to the intravenous  injection 
of antistreptococcic  serum  on  a  large  scale  on  the  assumption  of a 
streptococcus infection playing an  essential part in the pathology of 
poliomyelitis. 
CONCLUSIONS. 
The  antistreptococcic  serum  of  Nuzum  and  Willy  has  failed  to 
show in the monkey neutralizing or therapeutic power when applied by 
their methods against small doses of the virus of poliomyelitis.  Under 
the  same  conditions  the  serum  of  monkeys  recovered  from  experi- 
mental  poliomyelitis  proved  neutralizing  and  protective. 
The experimental and other evidence adduced by those who regard 
the  streptococcus as  playing  an  essential  part  in  the  pathology  of 
epidemic  poliomyelitis  and  the  antistreptococcic  sera as exhibiting 
therapeutic properties for man and monkeys is regarded as imperfect 
and  inconclusive. 
EXPLANATION OF  PLATES. 
PLATE 22. 
FIG. 1.  Monkey B.  7 days after the intracerebral injection of the incubated 
mixture of 0.2 cc. of virus filtrate  and 2 cc. of Nuzum and Willy's serum. 
FIG. 2.  Monkey B.  Cervical enlargement of the cord showing perivascular 
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PLATE 23. 
FIG.  3.  Monkey E.  9  days  after  the  intravenous  injection  of virus.  This 
monkey was treated with five intraspinal injections of 2 cc. each of Nuzum and 
Willy's serum. 
FIG.  4.  Monkey E.  Medulla,  showing perivascular infiltration,  hemorrhage, 
and neurophagocytosis.  X  192. 
PLATE 24. 
Fie..  5.  Monkey F.  Medulla,  showing congestion,  necrosis of gray  matter, 
cell  degeneration,  and  neurophagocytosis.  ×  240. THE JOURNAL OF  EXPERIMENTAL  MEDICINE VOL.  XXVIII.  PLATE  22. 
FIG.  1, 
FIG.  2. 
(Amoss and Eberson: Nuzum's antipoliomyelitic serum.) THE JOURNAL OF  EXPERIMENTAL MEDICINE VOL. XXVIII.  PLATE 23. 
F~G.  3. 
Fro.  4. 
(Amass and  Eberson: Nuzum's antipoliomyelitlc serum.) THE JOURNAL  OF  EXPERIMENTAL  MEDICINE VOL.  XXVIII,  PLATE  24. 
FIG.  5. 
(Amoss  and  Eberson:  Nuzum's antipoliomyelitic  serum.) 